Study of PF614 Compared to OxyContin® in Healthy Volunteers
Status:
Completed
Trial end date:
2018-01-10
Target enrollment:
Participant gender:
Summary
PF614 is an oxycodone prodrug that is designed for extended-release of oxycodone comparable
to OxyContin. This Single Ascending Dose (SAD) study is designed to assess the safety and
pharmacokinetics (PK) of PF614 in comparison to standard doses of OxyContin.